Tuesday, October 4, 2022

561.316.3330

Biotechnology News Magazine

Lupus Nephritis Market Insight, Epidemiology and Market Forecast 2032

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

The “Lupus Nephritis – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering.

This Lupus Nephritis Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Lupus Nephritis, historical and forecasted epidemiology as well as the Lupus Nephritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Report Highlights

  • In the coming years, the Lupus Nephritis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Lupus Nephritis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for Lupus Nephritis. The launch of emerging therapies will significantly impact the Lupus Nephritis market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Lupus Nephritis
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

The Lupus Nephritis market report provides current treatment practices, emerging drugs, Lupus Nephritis market share of the individual therapies, current and forecasted Lupus Nephritis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Lupus Nephritis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Lupus Nephritis Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Lupus Nephritis Pipeline Analysis
  • Lupus Nephritis Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Lupus Nephritis Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage
  • Lupus Nephritis Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

Lupus Nephritis Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Topics Covered:

1. Key Insights

2. Executive Summary

3. Lupus Nephritis: Market Overview at a Glance

3.1. Total Market Share (%) Distribution of Lupus Nephritis in 2019

3.2. Total Market Share (%) Distribution of Lupus Nephritis in 2032

4. Lupus Nephritis: Disease Background and Overview

5. Epidemiology and Patient Population

5.1. Key Findings

6. 7MM Total Prevalent Patient Population of LN

7. Country Wise-Epidemiology of Lupus Nephritis

8. Treatment

8.1. Treatment Goals

8.2. Medications

8.3. General Treatment

8.4. Treatment Guidelines

8.4.1. American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis

8.4.2. EULAR Guidelines for the treatment of Lupus Nephritis

8.4.3. KDIGO Guidelines For the treatment of Lupus Nephritis

9. Unmet Needs

10. Patient Journey

11. Case Studies

12. Marketed Therapies

12.1. LUPKYNISTM: Aurinia Pharmaceuticals

13. Key Cross Competitors

14. Emerging Therapies

14.1. Obinutuzumab: Roche

14.2. Anifrolumab: AstraZeneca

15. Other Promising Candidates

15.1. BI 655064: Boehringer Ingelheim

15.2. Iscalimab: Novartis

16. Lupus Nephritis: 7 Major Market Analysis

16.1. Key Findings

16.2. Market Size of Lupus Nephritis in 7MM

16.3. Market Size of Lupus Nephritis by Therapies in First Line Patients in 7MM

16.4. Market Size of Lupus Nephritis by Therapies in Second Line Patients in 7MM

17. United States Market Outlook

18. EU-5 Countries: Market Outlook

19. Japan: Market Outlook

20. Market Drivers

21. Market Barriers

22. SWOT Analysis

23. Market Access and Reimbursement

Companies Mentioned

  • Aurinia Pharmaceuticals
  • Roche
  • AstraZeneca
  • Boehringer Ingelheim
  • Novartis

For more information about this report visit here.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine